AlphaFold predicted structure
CHST6 · Q9GZX3

Mean pLDDT
90.3/ 100
Very high
395 residues
Confidence breakdown
- Very high(≥ 90)79%
- Confident(70–90)11%
- Low(50–70)3%
- Very low(< 50)7%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
carbohydrate sulfotransferase 6
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Congenital disorders of glycosylation
BIALLELIC, autosomal or pseudoautosomalCorneal abnormalities
BIALLELIC, autosomal or pseudoautosomalCorneal dystrophy
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalUndiagnosed metabolic disorders
BIALLELIC, autosomal or pseudoautosomalChildhood onset dystonia, chorea or related movement disorder
Structural eye disease
BIALLELIC, autosomal or pseudoautosomalmacular corneal dystrophy
aortic stenosis
hereditary disease
alopecia areata
medical procedure
aneurysm
Fuchs endothelial corneal dystrophy
posterior polymorphous corneal dystrophy
retinitis pigmentosa
early-onset non-syndromic cataract
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Carbohydrate sulfotransferase 6
Sulfotransferase that utilizes 3'-phospho-5'-adenylyl sulfate (PAPS) as sulfonate donor to catalyze the transfer of sulfate to position 6 of non-reducing N-acetylglucosamine (GlcNAc) residues of keratan (PubMed:11278593, PubMed:11352640, PubMed:12218059, PubMed:17690104). Cooperates with B4GALT4 galactosyltransferase and B3GNT7 N-acetylglucosaminyltransferase to construct and elongate the sulfated disaccharide unit [->3Galbeta1->4(6-sulfoGlcNAcbeta)1->] within keratan sulfate polymer. Involved in biosynthesis of keratan sulfate in cornea, with an impact on proteoglycan fibril organization and corneal transparency (PubMed:11278593, PubMed:12218059, PubMed:17690104). Involved in sulfation of endothelial mucins such as GLYCAM1 (PubMed:11352640)
CHST6 · Q9GZX3

Mean pLDDT
90.3/ 100
Very high
395 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0